Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990–2017 using hierarchical age-period-cohort analysis
Background Statistical evidence on breast cancer (BC) burden related to health and lifestyle
risk factors are valuable for health policy-making. This study aimed to compare the trends in …
risk factors are valuable for health policy-making. This study aimed to compare the trends in …
A hierarchical age–period–cohort analysis of breast cancer mortality and disability adjusted life years (1990–2015) attributable to modified risk factors among Chinese …
Limited studies quantified the age, period, and cohort effects attributable to different risk
factors on mortality rates (MRs) and disability-adjusted life years (DALYs) due to breast …
factors on mortality rates (MRs) and disability-adjusted life years (DALYs) due to breast …
Survival outcomes of breast cancer in sudanese women: a hospital-based study
HF Muddather, MMA Elhassan, A Faggad - JCO Global Oncology, 2021 - ascopubs.org
PURPOSE Breast cancer (BC) is the leading malignancy among Sudanese women. Yet,
data on survival are limited. This study aimed to determine 5-year overall survival (OS) of BC …
data on survival are limited. This study aimed to determine 5-year overall survival (OS) of BC …
XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis
Background Gene polymorphisms that affect nucleotide excision repair (NER) pathway may
link with higher susceptibility of breast cancer (BC); however, the significance of these …
link with higher susceptibility of breast cancer (BC); however, the significance of these …
Correlation of MSH2 exonic deletions and protein downregulation with breast cancer biomarkers and outcome in Pakistani women/patients
Mismatch repair (MMR) pathway is one of the underlying mechanisms of predisposition to
breast cancer (BC). The present study explored the association of MSH2 exonic deletions …
breast cancer (BC). The present study explored the association of MSH2 exonic deletions …
[HTML][HTML] Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis
T Zhang, S Sun, T Xia, Q Huang, Y Fu… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Objective Metabolic risks (MRs) are the primary determinants of breast cancer (BC) mortality
among women. This study aimed to examine the changing trends in BC mortality associated …
among women. This study aimed to examine the changing trends in BC mortality associated …
[HTML][HTML] Long-term survival and prognostic factors of breast cancer
A Olfatbakhsh, L Heidari, Z Omidi, M Ansari… - Archives of Iranian …, 2022 - ncbi.nlm.nih.gov
Background: Breast cancer survival rate is an important index for assessment of treatment
effect in reducing the mortality. Weaimed to determine the fifteen-year survival rate for breast …
effect in reducing the mortality. Weaimed to determine the fifteen-year survival rate for breast …
Breast Cancer: Epidemiology, Risk Factors and Survival Analysis in the Pakistani Population
S Zaib, N Masood, JS Khan… - Journal of University …, 2024 - journals.uol.edu.pk
Objective: To find out the association of genetic, reproductive and socio demographic factors
with breast cancer in Pakistani women along with the sur-vival percentage of patients having …
with breast cancer in Pakistani women along with the sur-vival percentage of patients having …
[HTML][HTML] Expression of Hormone Receptors and Human Epidermal Growth Factor2/Neu in Female Breast Cancer Patients
Overexpression of HER2/neu and estrogen receptors (ER) and/or progesterone receptors
(PR) are reported to be inversely associated with breast cancer (BC). The relationship …
(PR) are reported to be inversely associated with breast cancer (BC). The relationship …
Distinct genetic landscape and a low response to doxorubicin in a luminal-A breast cancer cell line of Pakistani origin
Background Breast cancers exhibit genetic heterogeneity which causes differential
responses to various chemotherapy agents. Given the unique demographic and genomic …
responses to various chemotherapy agents. Given the unique demographic and genomic …